江山股份(600389.SH)擬實施“中試裝置項目”及建設公司綜合樓 項目投資合計6777.87萬元
格隆匯 12 月 14日丨江山股份(600389.SH)公佈,公司第八屆董事會第七次會議審議通過了《關於實施“中試裝置項目”的議案》、《關於建設公司綜合樓的議案》,項目投資合計為6777.87萬元。
公司近幾年不斷加大研發投入,目前已儲備一批高效低毒、安全環保、對環境友好型除草劑、殺菌劑和殺蟲劑品種的小試技術。這些小試技術急需通過中試裝置進行放大驗證,以獲取工藝和工程化控制參數,為後續工業化提供安全可靠的設計參數。
項目名稱:中試裝置項目;項目建設內容:中試裝置包含間歇和連續化反應單元、後處理及公用工程等設施;項目總投資為4319.85萬元。資金來源為自籌。該項目不以盈利為目的。中試裝置投運後拿到的試驗產品主要用於產品登記、製劑配方研究或進行無害化處理,不出售流入市場,故不存在財務效益。
根據應急管理部門相關監管要求以及公司發展需要,公司擬在生產區外、公司用地內建設一幢集應急、辦公、會議、接待等功能為一體的綜合樓。項目名稱:新建綜合樓;項目建設規模:新建綜合樓總佔地面積為 1283平方米,建築面積為4244平方米;項目建設總投資為2458.02萬元。資金來源為自籌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.